Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment
Paper deals with the content of CD95+-cells in the blood of patients with ovarian cancer and benign tumors. Found that patients with a malignant process and low CD95+-cells before treatment and during chemotherapy have a poor survival. The initial increase in the relative level CD95+- cells has no e...
Main Authors: | N. G. Kormosh, T. N. Zabotina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/45 |
Similar Items
-
Spontaneous apoptosis of lymphocytes of ovary cancer patients
by: I. I. Antoneyeva, et al.
Published: (2007-06-01) -
Characteristics of lymphocyte subpopulations in the peripheral blood and lymph nodes of patients with ovarian cancer
by: I. Zh. Shubina, et al.
Published: (2014-11-01) -
Tertiary Lymphoid Structures and Cancer Prognosis (Brief Review)
by: R. A. Rustamkhanov, et al.
Published: (2020-01-01) -
Management and results of treatment of patients with refractory ovarian cancerr
by: N. G. Kormosh, et al.
Published: (2014-08-01) -
Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender
by: A. I. Stukan, et al.
Published: (2022-12-01)